Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124134863 | 12413486 | 3 | F | 20160517 | 20160721 | 20160527 | 20160801 | EXP | IT-JNJFOC-20160521987 | JANSSEN | 79.00 | YR | E | M | Y | 0.00000 | 20160801 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124134863 | 12413486 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | 0 | 20 | MG | TABLET | QD | ||||||
| 124134863 | 12413486 | 2 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | 202439 | 20 | MG | TABLET | QD | ||||||
| 124134863 | 12413486 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 0 | 600 | MG | TABLET | TID | |||||||
| 124134863 | 12413486 | 4 | SS | COLCHICINE. | COLCHICINE | 1 | Unknown | 0 | .5 | MG | UNSPECIFIED | QD | |||||||
| 124134863 | 12413486 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | 20 | MG | UNSPECIFIED | ||||||||
| 124134863 | 12413486 | 6 | C | PENTOXIFYLLIN | PENTOXIFYLLINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 124134863 | 12413486 | 7 | C | TRENTAL | PENTOXIFYLLINE | 1 | Unknown | 0 | 400 | MG | UNSPECIFIED | ||||||||
| 124134863 | 12413486 | 8 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | 0 | 5 | MG | UNSPECIFIED | ||||||||
| 124134863 | 12413486 | 9 | C | ENOXAPARIN | ENOXAPARIN | 1 | Unknown | 0 | 6000 | IU | UNSPECIFIED | BID | |||||||
| 124134863 | 12413486 | 10 | C | CARDIOASPIRIN | ASPIRIN | 1 | Unknown | 0 | 1 | DF | TABLET | ||||||||
| 124134863 | 12413486 | 11 | C | GLICLAZIDE | GLICLAZIDE | 1 | Unknown | HALF TABLET | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124134863 | 12413486 | 1 | Cerebrovascular accident prophylaxis |
| 124134863 | 12413486 | 2 | Atrial fibrillation |
| 124134863 | 12413486 | 3 | Pericarditis |
| 124134863 | 12413486 | 4 | Pericarditis |
| 124134863 | 12413486 | 6 | Reynold's syndrome |
| 124134863 | 12413486 | 7 | Reynold's syndrome |
| 124134863 | 12413486 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124134863 | 12413486 | DE |
| 124134863 | 12413486 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124134863 | 12413486 | Anaemia | |
| 124134863 | 12413486 | Hepatitis | |
| 124134863 | 12413486 | Nausea | |
| 124134863 | 12413486 | Pericardial effusion | |
| 124134863 | 12413486 | Renal failure | |
| 124134863 | 12413486 | Shock haemorrhagic | |
| 124134863 | 12413486 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124134863 | 12413486 | 1 | 20160510 | 20160517 | 0 | |
| 124134863 | 12413486 | 2 | 20160510 | 20160517 | 0 | |
| 124134863 | 12413486 | 3 | 20160429 | 20160518 | 0 | |
| 124134863 | 12413486 | 4 | 20160502 | 20160518 | 0 | |
| 124134863 | 12413486 | 9 | 20160503 | 20160509 | 0 |